Latest Raya Therapeutic News & Updates

See the latest news and media coverage for Raya. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Raya Therapeutic (Raya)

Biotechnology company developing ALS treatments

rayatherapeutic.com
Headquarters
Montreal, Canada
Founded year
2019
Company type
Private company
Number of employees
4–10

Last updated

Latest news about Raya Therapeutic (Raya)

In short: Raya advanced its ALS pipeline by securing a spot for RT1999 in the EXPERTS-ALS clinical trial and receiving multiple orphan drug designations.

Company announcements

Raya

Raya Therapeutic unveils Raya CARES pipeline

The pipeline features five clinical-stage compounds with unique mechanisms targeting ALS, PD, and neurodegenerative diseases. Each has established safety data. Raya plans Phase 2/3 trials within 12-18 months.

Raya

Raya announces compound selection for EXPERTS-ALS trial

One of five clinical-stage compounds advances toward ALS approval in University of Sheffield-led platform trial. Positive data could lead to registration trial.

Unlock all announcements with a

Media coverage

FOX40

Raya Therapeutic Announces FDA and EMA Orphan Drug Designations for ALS with RT1978 (epertinib)

The orphan drug designations (ODDs) are from both the FDA & EMA and for the treatment of Amyotrophic Lateral Sclerosis (ALS). MONTREAL, QUEBEC, CANADA, March...

Unlock all articles with a

Never miss news about Raya

Track Raya and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.